Marc Goodman Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
7
Avg Return
Past Year
Past Year
50%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
85.7%
Neutral
14.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Consumer Discretionary
Specialty Retail
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Initiated
| $30 |
87%
upside
| 1 | +21% |
0
%
| 21 Nov ‘25 1 month ago |
|
|
|
Outperform
Initiated
| $5 |
181%
upside
| 1 | +36% |
0
%
| 17 Nov ‘25 1 month ago |
|
|
|
Market Perform
Downgraded
| $18.50 |
14%
downside
| 1 | – |
–
| 23 Oct ‘25 2 months ago |
|
|
|
Outperform
Initiated
| $34 |
62%
upside
| 1 | +39% |
0
%
| 6 Oct ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $50 |
326%
upside
| 1 | -12% |
0
%
| 12 Aug ‘25 4 months ago |
|
|
|
Outperform
Upgraded
| $10 |
17%
downside
| 1 | +158% |
0
%
| 7 May ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $150 |
12%
downside
| 1 | +61% |
0
%
| 10 Feb ‘25 11 months ago |
|